Lisinopril And Hydrochlorothiazide Tablet
Product Images NDC 71335-2091

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lisinopril And Hydrochlorothiazide (NDC 71335-2091). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Lisinopril)

Chemical structure diagram of the active ingredient Lisinopril in Lisinopril and Hydrochlorothiazide Tablets, showing atoms and bonds including a phenyl group, amide bonds, and carboxyl groups, along with associated water molecules (2H2O).*

FDA Label Image

Chemical Structure (HCTZ)

Chemical structure of Lisinopril and Hydrochlorothiazide, the active ingredients in the tablet formulation shown. The diagram displays the molecular bonds and arrangement of atoms characteristic of these compounds.*

FDA Label Image

Label (Lbl713352091)

Label for Lisinopril and Hydrochlorothiazide Tablets 20 mg / 25 mg by Bryant Ranch Prepack. The label indicates a pink, round tablet imprinted with H152, features storage instructions (store at 20-25°C), and states the package contains 30 tablets. The label references comparison to Zestoretic 20/25 mg and includes the NDC 71335-2091.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.